Pursuant to the Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements )Regulation 2015, Sandu Pharmaceutical has informed that Linkintime India, the Registrar and Share Transfer Agent (RTA) of the Company has stopped Transfer on receipt of the request for Duplicate issue of Shares for the Shareholders. Details regarding the shareholders and certificates are attached.
The above information is a part of company’s filings submitted to BSE.